semaglutide mash pdufa therapy enters a more competitive era Semaglutide, a GLP-1R agonist, is

Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation

Trial for reduction of Ochratoxin A residues in fish feed by using nanoparticles of hydrated sodium aluminum silicates (NPsHSCAS) and copper oxide

Humira biosimilar erosion ongoing (USD 9B, down from ~USD 21B peak)

While BPC-157 and TB-500 rebuild tissue, KPV manages inflammation and GHK-Cu supports skin and connective tissue, creating a complete healing environment

Other Indications Under Study Type 2 Diabetes (TRANSCEND-T2D) TRANSCEND-T2D-1 was the first Phase 3 readout in type 2 diabetes, with Lilly reporting results on March 19, 2026